ALZN · CIK 0001677077 · operating
Alzamend Neuro, Inc. (ALZN) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $8 million, Alzamend Neuro, Inc. is a micro-cap company. The stock currently trades at $2.00, down 0.50% today, with a 52-week range of $1.58–$10.17.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-11.32 | $-11.32 | +23.0% | |
| 2024 | $-14.70 | $-14.70 | -9700.0% | |
| 2023 | $-0.15 | $-0.15 | — | |
| 2022 | — | — | — | |
| 2021 | — | — | — |